Castle Biosciences Inc.

CSTL | NASDAQ

Price Alert Chart Builder DCF Calculator

$34.99

-$0.35 (-0.99%)

At close: Sep 21, 2026, 4:00 PM ET

$34.99

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-24.16M	18.25M	-57.47M	-67.14M	-31.29M	-10.28M
Depreciation & Amortization	40.77M	16M	12.33M	10.54M	3.41M	472K
Stock-Based Compensation	45.89M	50.32M	51.22M	36.32M	21.74M	8.31M
Other Working Capital	5.79M	3.08M	6.56M	7.31M	384K	8.3M
Other Non-Cash Items	-5.53M	-6.97M	-4.86M	-19.5M	n/a	2.22M
Deferred Income Tax	-6.23M	1.4M	-223K	-1.88M	-8.74M	n/a
Change in Working Capital	13.6M	-14.13M	-6.63M	-7K	-4.1M	9.15M
Operating Cash Flow	64.35M	64.87M	-5.63M	-41.66M	-18.98M	9.87M
Capital Expenditures	-36.02M	-28.33M	-13.62M	-5.63M	-3.48M	-4.75M
Cash Acquisitions	-18.73M	18K	n/a	-26.97M	-63.18M	n/a
Purchase of Investments	-188.71M	-205.73M	-189.08M	-134.69M	n/a	n/a
Sales Maturities Of Investments	190.73M	183.9M	186.5M	n/a	n/a	n/a
Other Investing Acitivies	-7.64M	n/a	13K	742K	10K	3K
Investing Cash Flow	-60.37M	-50.14M	-16.18M	-166.55M	-66.66M	-4.75M
Debt Repayment	-115K	9.9M	-142K	-122K	-8K	-27.36M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-9.05M	-5.78M	-2.16M	1.64M	5.43M	3.21M
Financial Cash Flow	-6.96M	6.14M	-2.3M	1.52M	5.42M	305.89M
Net Cash Flow	-2.98M	20.87M	-24.11M	-206.69M	-80.22M	311.01M
Free Cash Flow	28.33M	36.54M	-19.25M	-47.29M	-22.47M	5.11M
Adj. Free Cash Flow	-17.57M	-13.78M	-70.47M	-83.61M	-44.21M	-3.2M
Maintenance CapEx	-33.42M	-9.47M	-798.22K	n/a	n/a	-3.88M
Growth CapEx	-2.6M	-18.85M	-12.82M	-5.63M	-3.48M	-868.22K
Owner Earnings	30.92M	55.39M	-6.42M	-41.66M	-18.98M	5.98M